他莫昔芬疗效中的遗传学研究：呼吁在标签上标注复发警告。 - Suppr

Suppr

超能文献

Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.

作者信息

Young Donna

出版信息

Am J Health Syst Pharm. 2006 Dec 1;63(23):2286, 2296. doi: 10.2146/news060026.

DOI:10.2146/news060026

PMID:17105997

Abstract

摘要

相似文献

Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.

Am J Health Syst Pharm. 2006 Dec 1;63(23):2286, 2296. doi: 10.2146/news060026.

PharmGKB summary: tamoxifen pathway, pharmacokinetics.

Pharmacogenet Genomics. 2013 Nov;23(11):643-7. doi: 10.1097/FPC.0b013e3283656bc1.

Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.

Future Oncol. 2010 Jun;6(6):877-80. doi: 10.2217/fon.10.65.

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

Am J Psychiatry. 2008 Oct;165(10):1251-5. doi: 10.1176/appi.ajp.2008.08040482.

Inherited gene affects tamoxifen's benefit in some breast cancers.

Mayo Clin Womens Healthsource. 2006 Jun;10(6):3.

Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort.

Br J Clin Pharmacol. 2023 Oct;89(10):3209-3216. doi: 10.1111/bcp.15827. Epub 2023 Jun 26.

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

Breast Cancer Res. 2010 Dec 20;12 Suppl 4(Suppl 4):S18. doi: 10.1186/bcr2747.

CYP2D6 and tamoxifen: DNA matters in breast cancer.

Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683.

Understanding CYP2D6 and its role in tamoxifen metabolism.

Oncol Nurs Forum. 2013 Nov;40(6):547-8. doi: 10.1188/13.ONF.547-548.

Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.

Clin Adv Hematol Oncol. 2008 Nov;6(11):825-33.

引用本文的文献

Pharmacogenomic discovery using cell-based models.

Pharmacol Rev. 2009 Dec;61(4):413-29. doi: 10.1124/pr.109.001461.

Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

J Mol Diagn. 2009 Sep;11(5):381-9. doi: 10.2353/jmoldx.2009.090003. Epub 2009 Jul 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.

作者信息

Young Donna

出版信息

Am J Health Syst Pharm. 2006 Dec 1;63(23):2286, 2296. doi: 10.2146/news060026.

DOI:10.2146/news060026

PMID:17105997

Abstract

摘要

相似文献

Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.

Am J Health Syst Pharm. 2006 Dec 1;63(23):2286, 2296. doi: 10.2146/news060026.

PharmGKB summary: tamoxifen pathway, pharmacokinetics.

Pharmacogenet Genomics. 2013 Nov;23(11):643-7. doi: 10.1097/FPC.0b013e3283656bc1.

Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.

Future Oncol. 2010 Jun;6(6):877-80. doi: 10.2217/fon.10.65.

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

Am J Psychiatry. 2008 Oct;165(10):1251-5. doi: 10.1176/appi.ajp.2008.08040482.

Inherited gene affects tamoxifen's benefit in some breast cancers.

Mayo Clin Womens Healthsource. 2006 Jun;10(6):3.

Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort.

Br J Clin Pharmacol. 2023 Oct;89(10):3209-3216. doi: 10.1111/bcp.15827. Epub 2023 Jun 26.

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

Breast Cancer Res. 2010 Dec 20;12 Suppl 4(Suppl 4):S18. doi: 10.1186/bcr2747.

CYP2D6 and tamoxifen: DNA matters in breast cancer.

Nat Rev Cancer. 2009 Aug;9(8):576-86. doi: 10.1038/nrc2683.

Understanding CYP2D6 and its role in tamoxifen metabolism.

Oncol Nurs Forum. 2013 Nov;40(6):547-8. doi: 10.1188/13.ONF.547-548.

Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.

Clin Adv Hematol Oncol. 2008 Nov;6(11):825-33.

引用本文的文献

Pharmacogenomic discovery using cell-based models.

Pharmacol Rev. 2009 Dec;61(4):413-29. doi: 10.1124/pr.109.001461.

Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

J Mol Diagn. 2009 Sep;11(5):381-9. doi: 10.2353/jmoldx.2009.090003. Epub 2009 Jul 30.